Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Serotonin (5-HT) regulates important biological and psychological processes including mood, and may be associated with the development of several psychiatric disorders. An association between psychopathology and genes that regulate 5-HT neurotransmission is a robust area of research. Identification of the genes responsible for the predisposition, development, and pharmacological response of various psychiatric disorders is crucial to the advancement of our understanding of their underlying neurobiology. This review highlights research investigating 5-HT transporter (5-HTTLPR) polymorphism, because studies investigating the impact of the 5-HTTLPR polymorphism have demonstrated significant associations with many psychiatric disorders. Decreased transcriptional activity of the S allele ("risk allele") may be associated with a heightened amygdala response leading to anxiety-related personality traits, major depressive disorder, suicide attempts, and bipolar disorder. By contrast, increased transcriptional activity of the L allele is considered protective for depression but is also associated with completed suicide, nicotine dependence, and attention deficit hyperactivity disorder. For some disorders, such as post-traumatic stress disorder and major depressive disorder, the research suggests that treatment response may vary by allele (such as an enhanced response to serotonin specific reuptake inhibitors in patients with major depressive disorder and post-traumatic stress disorder with L alleles), and for alcohol dependence, the association and treatment for S or L alleles may vary with alcoholic subtype. While some studies suggest that 5-HTTLPR polymorphism can moderate the response to pharmacotherapy, the association between 5-HTTLPR alleles and therapeutic outcomes is inconsistent. The discovery of triallelic 5-HTTLPR alleles (L(A)/L(G)/S) may help to explain some of the conflicting results of many past association studies, while concurrently providing more meaningful data in the future. Studies assessing 5-HTTLPR as the solitary genetic factor contributing to the etiology of psychiatric disorders continue to face the challenges of statistically small effect sizes and limited replication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120 · cited 9×
“In order to examine the association between 5-HTT genotype and depression, Risch et al(12) performed a metaanalysis of 14 replication studies (n = 14,250) and found that many of the trials failed to reproduce the results reported by Caspi et al.(7) Furthermore, other studies reviewed were only able to replicate the re…”
InfluentialLesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
Molecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357 · cited 2×
“92 Assuming that the serotonergic system is involved in the response to stimulant drugs used to treat ADHD, the influence of 5-HTT genotype on response to methylphenidate 0.5 mg/ kg/day in children meeting DSM-IV diagnostic criteria for ADHD was examined by Thaker et al. 90 While L A carriers…”
InfluentialSerotonin transporter genetic variation and the response of the human amygdala.
Hariri, A. R., Mattay, V. S., Tessitore, A., Kolachana, B., Fera, F., Goldman, D., Egan, M. F., & Weinberger, D. R. (2002) · Science · doi:10.1126/science.1071829 · Cited by 2,340
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Risch, N., Herrell, R., Lehner, T., Liang, K.-Y., Eaves, L., Hoh, J., Griem, A., Kovacs, M., Ott, J., & Merikangas, K. R. (2009) · JAMA · doi:10.1001/jama.2009.878 · Cited by 1,655 · cited 6×
“To test the G × E hypothesis more directly, the authors stratified the sample by number of stressful life events.(12) Contrary to the results previously reported,(7) they discovered no significant difference in allele frequency between those with and without depression,(12) and noted that the largest increase in S all…”
InfluentialAntidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Caspi, A., Hariri, A. R., Holmes, A., Uher, R., & Moffitt, T. E. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09101452 · Cited by 1,346
A Swedish National Twin Study of Lifetime Major Depression
Kendler, K. S., Gatz, M., Gardner, C. O., & Pedersen, N. L. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.109 · Cited by 794 · cited 1×
“2%, the heritability of depression is thought to be 31%–42%.(23) In 2003, a gene × environment (G × E) hypothesis was proposed, suggesting that because”
Serotonin Transporter (5-HTTLPR) Genotype and Amygdala Activation: A Meta-Analysis
Munafò, M. R., Brown, S. M., & Hariri, A. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.08.016 · Cited by 789 · cited 2×
“stimuli, thereby predisposing carriers to stress-related psychiatric disorders.(19)”
Antidepressants for smoking cessation
Hughes, J. R., Stead, L. F., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub3 · Cited by 567 · cited 1×
“85 Further, since antidepressants have demonstrated efficacy in smoking cessation, 86 it was theorized that 5-HTTLPR may influence smoking behavior.”
Serretti, A., Kato, M., De Ronchi, D., & Kinoshita, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001926 · Cited by 529 · cited 5×
“33 By contrast, the 5-HTT genotype was shown to have no effect on treatment outcome in patients treated with the tricyclic antidepressant nortriptyline (plasma doses 50–150 ng/mL), but L/L patients treated with paroxetine 30 mg/day had significant reductions in HAM-D scores from baseline, suggesting that the genotype…”
InfluentialAnguelova, M., Benkelfat, C., & Turecki, G. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001336 · Cited by 421 · cited 2×
“46 Notably, when the researchers included studies that were stratified by type of suicidal behavior, the association was attributable to studies investigating suicide attempters versus completers.”
Anguelova, M., Benkelfat, C., & Turecki, G. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001328 · Cited by 276 · cited 1×
“49 Given the heterogeneity of bipolar disorder, researchers 44 have interpreted the small effect sizes as suggestive of either a polygenic model for bipolar disorder susceptibility or a G × E interaction similar to that proposed for unipolar depression.”
Xie, P., Kranzler, H. R., Poling, J., Stein, M. B., Anton, R. F., Brady, K., Weiss, R. D., Farrer, L., & Gelernter, J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.153 · Cited by 264 · cited 4×
“For example, Xie et al 57 demonstrated that while the 5-HTTLPR genotype alone was not significantly associated with post-traumatic stress disorder, S carriers were at an increased risk of post-traumatic stress disorder in response to trauma as a child and as an adult.”
InfluentialRessler, K. J., Bradley, B., Mercer, K. B., Deveau, T. C., Smith, A. K., Gillespie, C. F., Nemeroff, C. B., Cubells, J. F., & Binder, E. B. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31052 · Cited by 140 · cited 1×
“These researchers concluded that their data suggest that the G × E interactions predict depressive symptoms may be differentially sensitive to levels of childhood trauma.(28)”
Association of the Serotonin Transporter Gene With Smoking Behavior
Kremer, I., Bachner-Melman, R., Reshef, A., Broude, L., Nemanov, L., Gritsenko, I., Heresco-Levy, U., Elizur, Y., & Ebstein, R. P. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.924 · Cited by 101
Cited by
Psychiatric Symptoms Across the Menstrual Cycle in Adult Women: A Comprehensive Review
Handy, A. B., Greenfield, S. F., Yonkers, K. A., & Payne, L. A. (2022) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000329 · Cited by 153
Genetic approaches to understanding post-traumatic stress disorder
Almli, L. M., Fani, N., Smith, A. K., & Ressler, K. J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001090 · Cited by 124
“…of association studies with 5-HTTLPR is that the polymorphism has been found to be tri-allelic (LA/ LG/S) in that a third functional allele (LG) has been identified (Nakamura et al., 2000); thus, earlier association studies may not reflect the full range of genetic variation (Kenna et al., 2012).”
Tiwari, A., & Gonzalez, A. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.01.006 · Cited by 71
Hing, B., Gardner, C., & Potash, J. B. (2014) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32265 · Cited by 47
Schiele, M. A., Kollert, L., Lesch, K.-P., Arolt, V., Zwanzger, P., Deckert, J., Ziegler, C., & Domschke, K. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.07.131 · Cited by 26
Metadata
- Authors
- Kenna, G.
- Venue
- Pharmacogenomics and Personalized Medicine
- Publisher
- Informa UK Limited
- Published
- 2012-01
- Volume
- 5
- Pages
- 19
- ISSN
- 1178-7066 (ISSN-L)
- OpenAlex
- W2019096454
- Cited by
- 163
- References
- 17
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.